Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
CERN | CERNER Corp | Gerberding Julie L. | Director | Jun 07, 2022 | Option Exercise | $95.00 | 15,032 | 1,428,040 | 0 | Jun 09, 2022, 05:24 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP, Chief Patient Officer | Feb 24, 2022 | Option Exercise | $73.51 | 9,550 | 702,021 | 48,712 | Feb 28, 2022, 04:17 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP, Chief Patient Officer | Nov 01, 2021 | Sale | $87.91 | 96,270 | 8,462,682 | 39,162 | Nov 03, 2021, 04:11 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, GI Pub Policy | Feb 26, 2021 | Option Exercise | $72.62 | 12,585 | 913,923 | 39,162 | Mar 02, 2021, 11:46 AM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, GI Pub Policy | Jul 17, 2020 | Sale | $80.00 | 36,285 | 2,902,976 | 44,751 | Jul 20, 2020, 04:53 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, GI Pub Policy | Feb 28, 2020 | Option Exercise | $76.56 | 7,371 | 564,324 | 44,409 | Mar 03, 2020, 05:30 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, GI Pub Policy | Jan 13, 2020 | Sale | $89.34 | 102,073 | 9,118,865 | 37,038 | Jan 15, 2020, 05:15 PM | |
CERN | CERNER Corp | Gerberding Julie L. | Director | Aug 22, 2019 | Sale | $71.82 | 7,928 | 569,389 | 8,128 | Aug 23, 2019, 04:11 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | Feb 25, 2019 | Option Exercise | $80.38 | 8,747 | 703,084 | 55,288 | Feb 27, 2019, 06:55 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | Nov 07, 2018 | Option Exercise | $64.91 | 72,436 | 4,701,748 | 82,481 | Nov 08, 2018, 04:31 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | May 15, 2018 | Sale | $59.66 | 9,972 | 594,963 | 45,717 | May 16, 2018, 12:33 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | Feb 27, 2018 | Option Exercise | $54.72 | 9,062 | 495,873 | 55,277 | Mar 01, 2018, 07:33 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | May 02, 2017 | Option Exercise | $62.38 | 1,078 | 67,246 | 45,338 | May 03, 2017, 09:52 AM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | Feb 27, 2017 | Option Exercise | $65.85 | 3,707 | 244,106 | 43,063 | Mar 01, 2017, 04:46 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | Nov 07, 2016 | Option Exercise | $50.78 | 171,046 | 8,685,276 | 124,638 | Nov 08, 2016, 11:51 AM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | May 06, 2016 | Option Exercise | $54.09 | 1,566 | 84,705 | 38,655 | May 09, 2016, 04:21 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | Feb 22, 2016 | Option Exercise | $50.77 | 3,377 | 171,450 | 35,986 | Feb 24, 2016, 12:37 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | May 08, 2015 | Sale | $46.94 | 84,576 | 3,970,345 | 70,353 | May 11, 2015, 01:33 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | May 02, 2015 | Option Exercise | $59.86 | 1,214 | 72,670 | 24,145 | May 05, 2015, 04:46 PM | |
MRK | Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | Feb 23, 2015 | Option Exercise | $58.30 | 2,736 | 159,509 | 21,374 | Feb 25, 2015, 11:27 AM |